PURPOSE: Use of electronic health records (EHRs) in health research may lead to the false assumption of complete event ascertainment. We estimated "observation windows" (OWs), defined as periods within which the assumption of complete ascertainment of events is more likely to hold, as a quality control approach to reducing the likelihood of this false assumption. We demonstrated the impact of OWs on estimating the rates of type II diabetes mellitus (diabetes) from HIV clinical cohorts. METHODS: Data contributed by 16 HIV clinical cohorts to the NA-ACCORD were used to identify and evaluate OWs for an operationalized definition of diabetes occurrence as a case study. Procedures included (1) gathering cohort-level data; (2) visualizing and summarizing gaps in observations; (3) systematically establishing start and stop dates during which the assumption of complete ascertainment of diabetes events was reasonable; and (4) visualizing the diabetes OWs relative to the cohort open and close dates to identify immortal person-time. We estimated diabetes occurrence event rates and 95% confidence intervals in the most recent decade that data were available (January 1, 2007, to December 31, 2016). RESULTS: The number of diabetes events decreased by 17% with the use of the diabetes OWs; immortal person-time was removed decreasing total person-years by 23%. Consequently, the diabetes rate increased from 1.23 (95% confidence interval [1.20, 1.25]) per 100 person-years to 1.32 [1.29, 1.35] per 100 person-years with the use of diabetes OWs. CONCLUSIONS: As the use of EHR-curated data for event-driven health research continues to expand, OWs have utility as a quality control approach to complete event ascertainment, helping to improve accuracy of estimates by removing immortal person-time when ascertainment is incomplete.
PURPOSE: Use of electronic health records (EHRs) in health research may lead to the false assumption of complete event ascertainment. We estimated "observation windows" (OWs), defined as periods within which the assumption of complete ascertainment of events is more likely to hold, as a quality control approach to reducing the likelihood of this false assumption. We demonstrated the impact of OWs on estimating the rates of type II diabetes mellitus (diabetes) from HIV clinical cohorts. METHODS: Data contributed by 16 HIV clinical cohorts to the NA-ACCORD were used to identify and evaluate OWs for an operationalized definition of diabetes occurrence as a case study. Procedures included (1) gathering cohort-level data; (2) visualizing and summarizing gaps in observations; (3) systematically establishing start and stop dates during which the assumption of complete ascertainment of diabetes events was reasonable; and (4) visualizing the diabetes OWs relative to the cohort open and close dates to identify immortal person-time. We estimated diabetes occurrence event rates and 95% confidence intervals in the most recent decade that data were available (January 1, 2007, to December 31, 2016). RESULTS: The number of diabetes events decreased by 17% with the use of the diabetes OWs; immortal person-time was removed decreasing total person-years by 23%. Consequently, the diabetes rate increased from 1.23 (95% confidence interval [1.20, 1.25]) per 100 person-years to 1.32 [1.29, 1.35] per 100 person-years with the use of diabetes OWs. CONCLUSIONS: As the use of EHR-curated data for event-driven health research continues to expand, OWs have utility as a quality control approach to complete event ascertainment, helping to improve accuracy of estimates by removing immortal person-time when ascertainment is incomplete.
Authors: Javier Andreu-Perez; Carmen C Y Poon; Robert D Merrifield; Stephen T C Wong; Guang-Zhong Yang Journal: IEEE J Biomed Health Inform Date: 2015-07-10 Impact factor: 5.772
Authors: Catherine R Lesko; Lisa P Jacobson; Keri N Althoff; Alison G Abraham; Stephen J Gange; Richard D Moore; Sharada Modur; Bryan Lau Journal: Int J Epidemiol Date: 2018-04-01 Impact factor: 7.196
Authors: Katherine P Liao; Tianxi Cai; Vivian Gainer; Sergey Goryachev; Qing Zeng-treitler; Soumya Raychaudhuri; Peter Szolovits; Susanne Churchill; Shawn Murphy; Isaac Kohane; Elizabeth W Karlson; Robert M Plenge Journal: Arthritis Care Res (Hoboken) Date: 2010-08 Impact factor: 4.794
Authors: Abel N Kho; Jennifer A Pacheco; Peggy L Peissig; Luke Rasmussen; Katherine M Newton; Noah Weston; Paul K Crane; Jyotishman Pathak; Christopher G Chute; Suzette J Bielinski; Iftikhar J Kullo; Rongling Li; Teri A Manolio; Rex L Chisholm; Joshua C Denny Journal: Sci Transl Med Date: 2011-04-20 Impact factor: 17.956
Authors: Bonnie B Dean; Jessica Lam; Jaime L Natoli; Qiana Butler; Daniel Aguilar; Robert J Nordyke Journal: Med Care Res Rev Date: 2009-03-11 Impact factor: 3.929
Authors: William R Hersh; Mark G Weiner; Peter J Embi; Judith R Logan; Philip R O Payne; Elmer V Bernstam; Harold P Lehmann; George Hripcsak; Timothy H Hartzog; James J Cimino; Joel H Saltz Journal: Med Care Date: 2013-08 Impact factor: 2.983
Authors: Jessie K Edwards; Stephen R Cole; Tiffany L Breger; Lindsey M Filiatreau; Lauren Zalla; Grace E Mulholland; Michael A Horberg; Michael J Silverberg; M John Gill; Peter F Rebeiro; Jennifer E Thorne; Parastu Kasaie; Vincent C Marconi; Timothy R Sterling; Keri N Althoff; Richard D Moore; Joseph J Eron Journal: Clin Infect Dis Date: 2022-09-14 Impact factor: 20.999
Authors: Thibaut Davy-Mendez; Sonia Napravnik; Joseph J Eron; Stephen R Cole; David Van Duin; David A Wohl; Kelly A Gebo; Richard D Moore; Keri N Althoff; Tonia Poteat; M John Gill; Michael A Horberg; Michael J Silverberg; Ni Gusti Ayu Nanditha; Jennifer E Thorne; Stephen A Berry Journal: AIDS Date: 2021-07-01 Impact factor: 4.632
Authors: Yuhang Qian; Richard D Moore; Sally B Coburn; Thibaut Davy-Mendez; Kathleen M Akgün; Kathleen A McGinnis; Michael J Silverberg; Jonathan A Colasanti; Edward R Cachay; Michael A Horberg; Charles S Rabkin; Jeffrey M Jacobson; M John Gill; Angel M Mayor; Gregory D Kirk; Kelly A Gebo; Ank E Nijhawan; Keri N Althoff Journal: J Acquir Immune Defic Syndr Date: 2022-01-01 Impact factor: 3.771
Authors: Jennifer S Lee; Elizabeth A Humes; Brenna C Hogan; Kate Buchacz; Joseph J Eron; M John Gill; Timothy R Sterling; Peter F Rebeiro; Viviane Dias Lima; Angel Mayor; Michael J Silverberg; Michael A Horberg; Richard D Moore; Keri N Althoff Journal: Clin Infect Dis Date: 2021-10-05 Impact factor: 9.079